AVE 33.3% 0.2¢ avecho biotechnology limited

"The company does not have the cash to see it through to a...

  1. 5,270 Posts.
    lightbulb Created with Sketch. 244
    "The company does not have the cash to see it through to a cashflow positive state so funding has to come from somewhere. That is a major source of uncertainty."

    Agreed, but there isn't any reason to conclude that the cash has to come from a new stock issue. I think it is far more likely to be earnings form operations that provides the needed cash flow: profits and royalties on ongoing commercial activity plus royalties and payments from other deals in the making but not yet announced.

    Let's put it this way: If this company can get to this stage of development and fail to nail down deals with cash up front over the next 6 to 12 months, then something is very, VERY wrong with the business plan.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $2.565K 874.4K

Buyers (Bids)

No. Vol. Price($)
29 40547400 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 39021116 27
View Market Depth
Last trade - 15.59pm 12/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.